Literature DB >> 26195054

Muscular dystrophy in a patient with multiple sclerosis. Another "double-trouble"?

Dimitrios Parissis1, Panagiotis Ioannidis1, Christos Bakirtzis2, Nikolaos Grigoriadis1, Dimitrios Karacostas1.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is considered a relatively common muscular dystrophy affecting approximately 1:15,000 individuals in the general population. Single case reports have described the rare co-occurrence of FSHD with other hereditary neuromuscular disorders, leading to atypical phenotypes. We report herein the case of a 26-year-old woman with genetically proven FSHD, who additionally developed otherwise typical multiple sclerosis (MS). Although there is no direct relationship between FSHD and MS, they might, nevertheless, share some common pathophysiological mechanisms, as recent research suggests. In particular, we comment on the potential, but not yet proven, role of immunological factors in the pathogenesis of FSHD.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dystrophy; Facioscapulohumeral; Multiple; Muscular; Sclerosis

Mesh:

Year:  2015        PMID: 26195054     DOI: 10.1016/j.msard.2015.06.007

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  2 in total

1.  Facioscapulohumeral muscular dystrophy (FSHD) and multiple sclerosis: a case report.

Authors:  Rosa Iodice; Lorenzo Ugga; Francesco Aruta; Aniello Iovino; Lucia Ruggiero
Journal:  Acta Myol       Date:  2020-03-01

2.  A 5-year clinical follow-up study from the Italian National Registry for FSHD.

Authors:  Liliana Vercelli; Fabiano Mele; Lucia Ruggiero; Francesco Sera; Silvia Tripodi; Giulia Ricci; Antonio Vallarola; Luisa Villa; Monica Govi; Louise Maranda; Antonio Di Muzio; Marina Scarlato; Elisabetta Bucci; Lorenzo Maggi; Carmelo Rodolico; Maurizio Moggio; Massimiliano Filosto; Giovanni Antonini; Stefano Previtali; Corrado Angelini; Angela Berardinelli; Elena Pegoraro; Gabriele Siciliano; Giuliano Tomelleri; Lucio Santoro; Tiziana Mongini; Rossella Tupler
Journal:  J Neurol       Date:  2020-08-19       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.